Recent years have witnessed remarkable advances in the field of diabetes treatment, with a particular focus on GLP-1 receptor agonists. Among these novel therapies, retatrutide and trizepatide are emerging as potential https://violayiqu517332.ttblogs.com/18835595/glp-1-receptor-agonists-retatrutide-and-trizepatide-advancements